Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two novel mutations in severe factor VII deficiency.

Keith Gomez1, Michael A Laffan, Geoffrey Kemball-Cook

  • 1Haemostasis and Thrombosis, MRC Clinical Sciences Centre, The Faculty of Medicine, Imperial College, Du Cane Road, London, UK.

British Journal of Haematology
|June 17, 2004
PubMed
Summary

This study identifies novel genetic mutations causing severe factor VII deficiency. These molecular defects impact protein folding, secretion, and function, leading to reduced factor VII levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparative analysis of routine hospital admission data for sickle cell anaemia, cystic fibrosis and haemophilia in England.

Scientific reports·2026
Same author

Fibroblast activity biomarkers are associated with mortality in severe COVID-19: a post-hoc analysis of a phase 2 clinical trial.

Respiratory research·2026
Same author

Menstrual outcomes are frequently overlooked in von Willebrand disease trials.

Research and practice in thrombosis and haemostasis·2026
Same author

Autoimmune cytopenias following alemtuzumab-induced renal transplant: clinical features and treatment outcomes.

Haematologica·2026
Same author

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.

Nature metabolism·2026
Same author

Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial.

Journal of thrombosis and haemostasis : JTH·2026

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Severe factor VII (FVII) deficiency is a rare bleeding disorder.
  • Understanding the molecular basis of FVII deficiency is crucial for diagnosis and potential therapies.

Observation:

  • Two families with severe FVII deficiency were analyzed.
  • Family I exhibited homozygosity for an 18 bp deletion in FVII exon 8 (g.10896-10913del).
  • Family II presented a compound heterozygous state for a missense mutation (FVII G117R) in exon 5 and a nonsense mutation (FVII R152X) in exon 6.

Findings:

  • The exon 8 deletion in Family I resulted in an in-frame deletion of six amino acids in the serine protease domain, affecting protein folding, secretion, stability, and function.
  • The G117R missense mutation in Family II, identified through evolutionary sequence comparison as critical for FVII structure, along with the R152X nonsense mutation, severely impacted protein folding, secretion, or stability.

Related Experiment Videos

  • Both molecular defects led to significantly reduced FVII antigen and activity levels in patient plasma.

    • Implications:

    • These findings elucidate novel molecular mechanisms underlying severe factor VII deficiency.
    • Identifying specific mutations aids in genetic counseling and personalized medicine approaches for bleeding disorders.
    • Further research into the structure-function relationship of FVII can inform the development of targeted treatments.